Exact Mass: 570.3685209999999
Exact Mass Matches: 570.3685209999999
Found 363 metabolites which its exact mass value is equals to given mass value 570.3685209999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyrrhoxanthinol
Pyrrhoxanthinol is found in mollusks. Pyrrhoxanthinol is a constituent of Mytilus edulis (blue mussel) Constituent of Mytilus edulis (blue mussel). Pyrrhoxanthinol is found in mollusks.
Hericenone F
Hericenone F is found in mushrooms. Hericenone F is a constituent of the edible lions mane mushroom Hericium erinaceum. Constituent of the edible lions mane mushroom Hericium erinaceum. Hericenone F is found in mushrooms.
Ganoderic acid Mk
Ganoderic acid Q is found in mushrooms. Ganoderic acid Q is a constituent of the cultured mycelium of Ganoderma lucidum (reishi)
Hericenone C
Hericenone C is found in mushrooms. Hericenone C is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericenone C is found in mushrooms.
Ganodermic acid P2
Ganoderic acid P is found in mushrooms. Ganoderic acid P is a constituent of the cultured mycelium of Ganoderma lucidum (reishi).
3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid
3beta,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11)24-trien-26-oic acid is found in mushrooms. 3beta,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11)24-trien-26-oic acid is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). 3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid is found in mushrooms.
carbenoxolone
DG(8:0/6 keto-PGF1alpha/0:0)
DG(8:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/8:0/0:0)
DG(6 keto-PGF1alpha/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/6 keto-PGF1alpha)
DG(8:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/0:0/8:0)
DG(6 keto-PGF1alpha/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/TXB2/0:0)
DG(8:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(TXB2/8:0/0:0)
DG(TXB2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/TXB2)
DG(8:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(TXB2/0:0/8:0)
DG(TXB2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Pyrrhoxanthinol 5,8-furanoxide
3alpha-Carboxyacetoxy-24-methylene-23-oxolanost-8-en-26-oic acid
15alpha,22S-Diacetoxy-3beta-hydroxylanosta-7,9(11),24E-trien-26-oic acid
1-benzoyl-11-(3,7-dimethylocta-2,6-dienyl)-6,6,13,13-tetramethyl-5-(1-methylethyl)tetracyclo[7.3.1.1(3,11).0(3,7)]tetradecane-2,12,14-trione|hypersampsone G
3-[hydroxy(phenyl)methylene]-6-methyl-1,5,7-tris(3-methyl-2-buten-1-yl)-6-(4-methyl-3-penten-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
3beta-angeloyl-2beta,23-dihydroxyolean-12-en-28-oic acid
3beta,25-Epoxy-3alpha-hydroxy-22beta-(2-methylbutan-1-oyloxy)olean-12-ene-28-oic acid
Di-Ac,Me ester-(2alpha,3beta)-2,3-Dihydroxy-12-oleanen-28-oic acid
2alpha,3beta-Diacetoxy-ursen-(12)-saeure-(28)-methylester|2alpha.3beta-Diacetoxy-Delta12-ursen-28-saeuremethylester|methyl 2alpha,3beta-diacetoxyurs-12-en-28-oate|methyl 2alpha-hydroxyursolate diacetate|methyl diacetylcorosolate
Di-Ac,Me ester -3beta-3,23-Dihydroxy-12-ursen-28-oic acid|Di-Ac,Me ether-3beta-3,23-Dihydroxy-12-ursen-28-oic acid
Spinosic acid methylester-diacetat|Spinosinsaeure A-methylesterdiacetat
(e)-5,6-dihydroxy-3-(3-hydroxy-5-oxo-4-undecylfuran-2(5h)-ylidene)-7-undecylbenzofuran-2(3h)-one
(3beta,19alpha,22beta)-3,19-dihydroxy-22-[(3-methylbut-2-enoyl)oxy]urs-12-en-28-oic acid
3.16-Di-O-acetyl-echinocystsaeure-methylester (3beta.16alpha-Diacetoxy-Delta12-oleanensaeure-(28)-methylester)|3beta,16alpha-diacetoxy-olean-12-en-28-oic acid methyl ester|3beta,16alpha-Diacetoxy-olean-12-en-28-saeure-methylester|3beta.16alpha-Diacetoxy-oleanen-(12)-saeure-(28)-methylester|diacetyl methyl echinocystate|Echinocystsaeure methylesterdiacetat|O,O-Diacetyl-echinocystsaeure-methylester
12alpha-(3-propanoyloxypentanoyloxy)-20,24-dimethyl-24-oxoscalara-16-en-25-al
13-benzoyl-6,6,8,14,14-pentamethyl-11,15-di(3-methyl-2-butenyl)-9-oxatetracyclo[11.3.1.01,10.03,8]heptadec-10-ene-12,17-dione
3beta,23-Diacetoxy-olean-12-en-28-saeure-methylester|3beta.23-diacetoxy-oleanen-(12)-oic acid-(28)-methyl ester|3beta.23-Diacetoxy-oleanen-(12)-saeure-(28)-methylester|Delta12-3beta.23-Diacetoxy-oleanen-28-saeuremethylester|Diacetylhederagenin-methylester|Diacetylhederageninmethylester|methyl hederagenin diacetate
2,3-Di-Ac-(2alpha,3beta,18beta)-2,3,18-Trihydroxy-5,12-oleanadien-28-oic acid
(8R)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-[(2R,3R)-3-methyl-3-(4-methylpen-3-ten-1-yl)oxiranyl]tricyclo[3.3.1.13,7]decane-2,4,9-trione|hyperandrone A
(11R*)-1-benzoyl-6,6,12,12-tetramethyl-9-(3,7-dimethylocta-2,6-dienyl)-11-(3-methyl-2-butenyl)-7-oxatricyclo[7.3.1.0(3,8)]trideca-3(8)-ene-2,13-dione|hypersampsone K
11(12)-Benzoyl,12(11)-(3-methylbatanoyl)-3,8,11,12,14-Pentahydroxypregnan-20-one
24-Hydroxy-22beta-angeloyloxy-epioleanolsaeure|24-Hydroxy-22beta-angeloyloxy-oleanolsaeure
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000845831]
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based: Match]
6-benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone [IIN-based on: CCMSLIB00000845834]
Pyrrhoxanthinol
Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 20 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
Carbenoxolone
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
Ile Pro Arg Trp
Ile Pro Trp Arg
Ile Arg Pro Trp
Ile Arg Trp Pro
Ile Trp Pro Arg
Ile Trp Arg Pro
Leu Pro Arg Trp
Leu Pro Trp Arg
Leu Arg Pro Trp
Leu Arg Trp Pro
Leu Trp Pro Arg
Leu Trp Arg Pro
Pro Ile Arg Trp
Pro Ile Trp Arg
Pro Leu Arg Trp
Pro Leu Trp Arg
Pro Arg Ile Trp
Pro Arg Leu Trp
Pro Arg Trp Ile
Pro Arg Trp Leu
Pro Trp Ile Arg
Pro Trp Leu Arg
Pro Trp Arg Ile
Pro Trp Arg Leu
Arg Ile Pro Trp
Arg Ile Trp Pro
Arg Leu Pro Trp
Arg Leu Trp Pro
Arg Pro Ile Trp
Arg Pro Leu Trp
Arg Pro Trp Ile
Arg Pro Trp Leu
Arg Trp Ile Pro
Arg Trp Leu Pro
Arg Trp Pro Ile
Arg Trp Pro Leu
Trp Ile Pro Arg
Trp Ile Arg Pro
Trp Leu Pro Arg
Trp Leu Arg Pro
Trp Pro Ile Arg
Trp Pro Leu Arg
Trp Pro Arg Ile
Trp Pro Arg Leu
Trp Arg Ile Pro
Trp Arg Leu Pro
Trp Arg Pro Ile
Trp Arg Pro Leu
Ganodermic acid P2
Ganoderic acid Mk
3a,15a-Diacetoxy-22R-hydroxylanosta-7,9(11),24-trien-26-Oic acid
Hericenone C
Hericenone F
N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-4,4-dimethyl-3-oxovaleramide
tris(2-ethylhexyl) 2-(acetyloxy)propane-1,2,3-tricarboxylate
Olean-12-eno[2,3-c][1,2,5]oxadiazol-28-oic acid phenylmethyl ester
Titanium, tris2-(2-aminoethyl)aminoethanolato-.kappa.O2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.O-, (OC-6-22)-
C24H54N6O6Ti (570.3584093999999)
2-[3-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]-1-propen-1-yl]-3-ethyl-1,1-dimethyl-1H-benz[e]indolium inner salt
tert-butyl 2,7-diazaspiro[4.5]decane-2-carboxylate hemioxalate
(5Z)-5-[(2E,4E,6E,8E)-11-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-2,9-dimethylundeca-2,4,6,8-tetraen-10-ynylidene]-3-[(E)-2-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethenyl]furan-2-one
2-[[(2R)-3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(2R,4R,6S,8S,10S)-2,4,6,8-tetrahydroxy-1-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]pentacosan-10-yl acetate
(2S,4aS,6aS,6bR,10S,12aS,14bR)-10-(3-carboxy-1-oxopropoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-15-[(3S,5R)-5-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethyl-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] 3-methylbut-2-enoate
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-(3-carboxy-1-oxopropoxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
6-Benzyl-3-butan-2-yl-9-(7-hydroxy-6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-(4-methoxyphenyl)urea
2,3-dihydroxypropyl [2-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propyl] hydrogen phosphate
[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H55N2O6P (570.3797539999999)
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
C30H55N2O6P (570.3797539999999)
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
2-[[(2R)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-phosphonooxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
2-[[(2R)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
3alpha,15alpha-Diacetoxy-(22R)-hydroxylanosta-7,9(11),24-trien-26-oic acid
cryptocaryol B
A member of the class of 2-pyranones that is 5,6-dihydro-2H-pyran-2-one substituted by a 10-(acetyloxy)-2,4,6,8-tetrahydroxypentacosyl group at position 6.It has been isolated from Cryptocarya species.
TG(32:6)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
GLP-1(32-36)amide
GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide could inhibit weight gain and modulate whole body glucose metabolism in diabetic mice[1][2].